Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
about
A phage display selected 7-mer peptide inhibitor of the Tannerella forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-Trp-Phe-ProModulation of Porphyromonas gingivalis proteinase activity by suboptimal doses of antimicrobial agents.Intracellular localization of Treponema denticola chymotrypsin-like proteinase in chronic periodontitisHost-mediated resolution of inflammation in periodontal diseases.Evaluation of the effect of allograft with doxycycline versus the allograft alone in the treatment of infrabony defects: A controlled clinical and radiographical study.Biotic acts of antibioticsPotential oral health benefits of cranberry.Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases.Host modulation by therapeutic agents.Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis.Pleiotropy of chemically modified tetracycline in periodontitis.Clarithromycin attenuates myocardial ischemia-reperfusion injury.Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.Chlorhexidine arrests subclinical degradation of dentin hybrid layers in vivo.Host modulation therapy with anti-inflammatory agents.
P2860
Q28484676-FBBDEEF2-DE53-41D9-96E4-FA51C143946FQ33194322-0DFFBDC1-11F7-4C50-B829-8DD6550A3FA2Q33850771-593DF9C2-1780-463B-A514-4F2886038BACQ36362712-C7B4099F-7BF3-4E11-9204-B895B492CEAEQ37065790-CF12E52B-8C29-4F8F-A6CB-8BA1215E963DQ37101851-47CDAA8D-FD52-45AD-A4A1-5A02B16F4C03Q37229299-656C5024-AAEE-403A-9CD5-0CA52B9474A7Q37769021-93ED7665-845B-47DC-A03E-234D0ECB237CQ37800572-D6F96864-0388-46D0-9FF2-2F55A5C28F6BQ38248012-786DF84B-B831-493D-94CA-65EB12AB0B72Q41773371-2A6B75AF-4984-4862-B13D-62DE0ECF09F0Q42545439-0AA46013-6A62-42A1-BFEA-BC5A00A32CFFQ42643466-B8BDD31E-7CBA-4436-BCEA-CC445715A1D5Q42956440-F9A8DB7F-FCA2-4D09-902B-199145C8B8F8Q44001600-DC98868A-22C8-4375-8C7F-4AB59CAAC630Q46616143-AD4993AE-577E-414B-A9BF-3CAE5F45BD5CQ48585276-9F217597-1BCE-436C-A311-A2D4CB07A101
P2860
Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inhibition of proteolytic, ser ...... fied tetracycline derivatives.
@ast
Inhibition of proteolytic, ser ...... fied tetracycline derivatives.
@en
type
label
Inhibition of proteolytic, ser ...... fied tetracycline derivatives.
@ast
Inhibition of proteolytic, ser ...... fied tetracycline derivatives.
@en
prefLabel
Inhibition of proteolytic, ser ...... fied tetracycline derivatives.
@ast
Inhibition of proteolytic, ser ...... fied tetracycline derivatives.
@en
P2093
P2860
P356
P1476
Inhibition of proteolytic, ser ...... fied tetracycline derivatives.
@en
P2093
McNamara T
Plamondon P
Ramamurthy NS
P2860
P356
10.1902/JOP.2002.73.1.79
P407
P577
2002-01-01T00:00:00Z